BRIEF-Regenxbio and Biogen enter agreement for development of gene therapy treatments
May 16, 2016 at 07:16 AM EDT
* Regenxbio and Biogen enter exclusive license agreement for the development of gene therapy treatments for rare genetic vision disorders